Sales decline 16.90% to Rs 110.95 crore
Net loss of Astrazeneca Pharma India reported to Rs 2.88 crore in the quarter ended March 2017 as against net profit of Rs 0.56 crore during the previous quarter ended March 2016. Sales declined 16.90% to Rs 110.95 crore in the quarter ended March 2017 as against Rs 133.51 crore during the previous quarter ended March 2016.For the full year,net profit rose 364.64% to Rs 24.44 crore in the year ended March 2017 as against Rs 5.26 crore during the previous year ended March 2016. Sales declined 0.03% to Rs 526.31 crore in the year ended March 2017 as against Rs 526.46 crore during the previous year ended March 2016.
ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales110.95133.51 -17 526.31526.46 0 OPM %-4.282.40 -5.583.12 - PBDT1.685.30 -68 49.0323.19 111 PBT-2.001.06 PL 33.205.76 476 NP-2.880.56 PL 24.445.26 365
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
